About
About Avecho
Board & Leadership
TPM
®
Technology
Portfolio
Pipeline
Phase III Trial
Cannabinoids
Pharmaceutical
Animal Health
Manufacturing
Invest
Investor Centre
Media Centre
Contact
Hit enter to search or ESC to close
Change of Registered Office and Principal Place of Business
January 20, 2017
Click here to read more
Post navigation
Previous Post
Phosphagenics Newsletter – December 2016
Next Post
Phosphagenics Signs Non-Binding Term Sheet for Oxymorphone Patch in Japan
Related Posts
Phosphagenics Initiates Oxycodone Patch Dosing in Phase 2 Clinical Trial
April 17, 2015
First Patient Dosed in Phase III Insomnia Trial
May 16, 2024
May 16, 2024
Phosphagenics Reports Positive Resuls for Weaner Pig Efficiency Trial
January 20, 2016
